Prostate Cancer Patient Articles & Analysis
4 articles found
Flotufolastat F 18 binds to prostate-specific membrane antigen (PSMA) (IC50= 4.4 nM) expressed on cells, including prostate cancer cells. In patients with recurrent prostate cancer who require local treatment, positron emission tomography (PET) with an 18F-labeled ligand provides accurate ...
While Movember is not just about prostate cancer, it is a great place to start; prostate cancer is the second most common cancer among men worldwide1, and the second leading cause of cancer death in American men.2 In the UK, more than 52,000 men are diagnosed with prostate ...
Unsurprisingly, doctors and hospitals saw fewer patients for unrelated COVID-19 conditions. Consistent with pandemic shutdowns and initial fear, several studies show a similar decreasing trend in cancer diagnosis, with prostate cancer dropping the most.2 During the first wave, patient visits dropped and then ...
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s micro-ultrasound and EDAP’s Focal One® ...